Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort ascending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort ascending Business Functional Area Date Posted
Utilities Maintenance & Reliability Engineer - Site Amiria Egypt Operations Innovative Medicines Technical Operations Aug 19, 2024
Associate Director for Information Security and Compliance, M&A Team Prague Czech Republic Operations CTS Technology Transformation Aug 20, 2024
Assoc. Dir. DDIT Dev. Business Analyst, Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 21, 2024
Project Engineer (Design Phase)_RLT Sasayama Sasayama Japan Operations Innovative Medicines Technical Operations Sep 03, 2024
Site Engineering Head / Directeur Ingénierie et Maintenance (m/f/d) Huningue France Operations Innovative Medicines Technical Operations Sep 03, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit & Finance Aug 22, 2024
Associate Director, Business Analyst, DDIT Dev., Technical Research & Development (TRD) Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 22, 2024
Sr Specialist DDIT IM JP & APMA Soln Int Selangor Malaysia Operations CTS Technology Transformation Aug 22, 2024
Tactical planner İstanbul Kurtköy Turkey Operations Innovative Medicines Technical Operations Aug 23, 2024
Associate Manager - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Manager - Field Effectiveness Hyderabad (Office) India Operations CTS Marketing Sep 03, 2024
Buyer with German Prague Czech Republic Operations CTS Procurement Aug 23, 2024
Associate Director, Veeva CRM Architect Barcelona Gran Vía Spain Operations CTS Technology Transformation Sep 03, 2024
Site Engineering Head Millburn USA Operations Innovative Medicines Technical Operations Aug 23, 2024
Responsabil produse & Expert în validare Targu Mures Romania Operations Innovative Medicines Technical Operations Sep 03, 2024
Director- Enterprise Architect(Architecture Design/Cross functional - SAP Implementation) Hyderabad (Office) India Operations CTS Technology Transformation Sep 03, 2024
Tehnolog proizv. inženiringa lokacije za področje avtomatizacije (m/ž/d) / Engineer Multidiscipline - automation area (m/f/d) Mengeš Slovenia Operations Innovative Medicines Technical Operations Aug 27, 2024
Buyer with Italian Prague Czech Republic Operations Innovative Medicines Procurement Sep 15, 2024
Global Procurement Category Manager Biologics and Cell & Gene Prague Czech Republic Operations Innovative Medicines Procurement Sep 10, 2024
Enterprise Architecture and Integrations Director - Americas INSURGENTES Mexico Operations CTS Technology Transformation Sep 10, 2024
Associate Director - LAN Sol. Architect (CZ, Spain, Mexico) Prague Czech Republic Operations CTS Technology Transformation Sep 11, 2024
Lehrling Elektrotechnik Schaftenau Austria Operations Innovative Medicines Others Sep 11, 2024
Lehre Labortechnik Schaftenau Austria Operations Innovative Medicines Others Sep 11, 2024
Lehrling Mechatronik Schaftenau Austria Operations Innovative Medicines Others Sep 11, 2024
Sr. Specialist Qualification Engineer INSURGENTES Mexico Operations CTS Technology Transformation Sep 11, 2024
Elektrotechniker (m/f/d), Kundl, Tirol Kundl Austria Operations Innovative Medicines Technical Operations Sep 12, 2024
Techniker/Mechatroniker/Mechaniker/Elektriker/Schlosser (m/f/d) Kundl, Schaftenau Schaftenau Austria Operations Innovative Medicines Technical Operations Sep 12, 2024
Data Engineering Manager - Data Services Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Sep 12, 2024
QC Analyst/ Specialist Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 13, 2024
Business Analyst – Biomedical research with Generative AI Expertise Hyderabad (Office) India Operations CTS Technology Transformation Sep 13, 2024
Vodja investicijskih projektov (m/ž/d) / Engineering Project Manager (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations Sep 13, 2024
Senior Analyst- US Pharma Analytics Hyderabad (Office) India Operations CTS Marketing Sep 16, 2024
Quality Assurance Manager - QP/RP Amsterdam Netherlands Operations Innovative Medicines Quality Sep 17, 2024
Senior Manager - Compliance and Risk Operations Hyderabad (Office) India Operations CTS Legal & Intellectual Property & Compl. Sep 18, 2024
Functional Lead, Compliance Analytics and Reporting Telangana India Operations CTS Legal & Intellectual Property & Compl. Sep 18, 2024
Sr. Spec. DDIT IES Workforce Mgmt. Hyderabad (Office) India Operations CTS Technology Transformation Oct 03, 2024
Manager, Evidence Generation Hyderabad (Office) India Operations CTS Market Access Oct 03, 2024
Spec. DDIT IES CIS Security Hyderabad (Office) India Operations CTS Technology Transformation Oct 03, 2024
Associate Director DDIT ISC CSOC Engineering Prague Czech Republic Operations CTS Technology Transformation Oct 03, 2024
Functional Architect (Salesforce/ Patient Services) Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 03, 2024
QC Specialist II (m/f/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality Oct 03, 2024
Director- Data Science Hyderabad (Office) India Operations CTS Marketing Oct 03, 2024
QA Compliance Expert – Reg CMC Facilitator Schaftenau Austria Operations Innovative Medicines Quality Oct 03, 2024
Specialist upravljanja kakovosti dobaviteljev II (m/ž/d)/ QA supplier management specialist II (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Quality Oct 03, 2024
Validation Lead Schaftenau Austria Operations Innovative Medicines Technical Operations Oct 03, 2024
QC Analyst IV Tuas South Avenue Singapore Operations Innovative Medicines Quality Oct 03, 2024
Sr. Spec. DDIT IES Solution Delivery INSURGENTES Mexico Operations CTS Technology Transformation Oct 03, 2024
Associate Director OPx Process Excellence Hyderabad (Office) India Operations CTS Technology Transformation Oct 03, 2024
QC Analyst III Tuas South Avenue Singapore Operations Innovative Medicines Quality Oct 03, 2024
Manager Economic Modelling Hyderabad (Office) India Operations CTS Market Access Oct 03, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only